Ke Cheng

617 total citations
43 papers, 398 citations indexed

About

Ke Cheng is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Ke Cheng has authored 43 papers receiving a total of 398 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 17 papers in Pulmonary and Respiratory Medicine and 9 papers in Surgery. Recurrent topics in Ke Cheng's work include Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Genomics and Diagnostics (5 papers). Ke Cheng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Pancreatic and Hepatic Oncology Research (8 papers) and Cancer Genomics and Diagnostics (5 papers). Ke Cheng collaborates with scholars based in China, United States and Pakistan. Ke Cheng's co-authors include Jiyan Liu, Meng Qiu, Ye Chen, Xingchen Peng, Jun Ge, Dan Cao, Longhao Li, Dong Hang, Kexun Zhou and Shuo Li and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Scientific Reports.

In The Last Decade

Ke Cheng

40 papers receiving 387 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ke Cheng China 12 151 133 84 79 68 43 398
Alessandra Cocomazzi Italy 11 106 0.7× 116 0.9× 73 0.9× 72 0.9× 48 0.7× 17 363
Graziella Malaponte Italy 9 125 0.8× 241 1.8× 56 0.7× 49 0.6× 67 1.0× 10 481
Young-Soon Na South Korea 12 179 1.2× 271 2.0× 42 0.5× 78 1.0× 70 1.0× 18 461
Jietao Lin China 12 96 0.6× 136 1.0× 34 0.4× 54 0.7× 67 1.0× 39 380
Binyan Lin China 7 241 1.6× 178 1.3× 75 0.9× 142 1.8× 40 0.6× 9 456
Domenico Germano Italy 10 178 1.2× 137 1.0× 65 0.8× 122 1.5× 34 0.5× 22 410
Carolina Ortiz Spain 9 218 1.4× 158 1.2× 45 0.5× 74 0.9× 88 1.3× 27 433
Ruba Al‐Abdulla Spain 12 179 1.2× 216 1.6× 113 1.3× 51 0.6× 118 1.7× 20 465
Eufemia Savino Italy 13 161 1.1× 164 1.2× 33 0.4× 51 0.6× 122 1.8× 17 430

Countries citing papers authored by Ke Cheng

Since Specialization
Citations

This map shows the geographic impact of Ke Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Cheng more than expected).

Fields of papers citing papers by Ke Cheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Cheng. The network helps show where Ke Cheng may publish in the future.

Co-authorship network of co-authors of Ke Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Cheng. A scholar is included among the top collaborators of Ke Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Cheng. Ke Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Ke, Zixin Chen, Yu Cai, et al.. (2024). PLEK2 promotes migration and invasion in pancreatic ductal adenocarcinoma by MMP1 through IL-17 pathway. Molecular and Cellular Biochemistry. 480(4). 2401–2412. 1 indexed citations
2.
3.
Meng, Xiangqian, Tingting Han, Liao Xue, et al.. (2023). The influence of male HBV infection on sperm quality, embryonic development, and assisted reproductive outcomes. Human Reproduction. 39(1). 43–52. 2 indexed citations
4.
Cheng, Ke, Qin Liu, Xiaoling Zhou, et al.. (2023). Expression of CD22 in Triple-Negative Breast Cancer: A Novel Prognostic Biomarker and Potential Target for CAR Therapy. International Journal of Molecular Sciences. 24(3). 2152–2152. 9 indexed citations
5.
6.
Hong, Liangli, Qi Zhou, Ke Cheng, et al.. (2023). CD22 is a potential target of CAR-NK cell therapy for esophageal squamous cell carcinoma. Journal of Translational Medicine. 21(1). 710–710. 10 indexed citations
7.
8.
9.
10.
Wu, Kai, Kun Peng, Zhiqiang Qiu, et al.. (2020). High level of RNF187 contributes to the progression and drug resistance of osteosarcoma. Journal of Cancer. 11(6). 1351–1358. 6 indexed citations
11.
Ding, Jing, Yueting Zhu, Lie Yang, et al.. (2018). 14-3-3zeta is involved in the anticancer effect of metformin in colorectal carcinoma. Carcinogenesis. 39(3). 493–502. 5 indexed citations
12.
Zhao, Yang, Ye Chen, Ke Cheng, et al.. (2018). Renal Ewing sarcoma treated with apatinib. Anti-Cancer Drugs. 29(7). 702–704. 3 indexed citations
13.
Wu, Jing, Ke Cheng, Yang Du, et al.. (2015). Recurrent Penile Squamous Cell Carcinoma Successfully Treated With Cetuximab, Chemotherapy, and Radiotherapy. Clinical Genitourinary Cancer. 14(1). e135–e137. 4 indexed citations
14.
Yang, Yu, Yang Du, Cong Li, et al.. (2015). Hepatitis B virus reactivation and hepatitis in gastrointestinal cancer patients after chemotherapy. Cancer Chemotherapy and Pharmacology. 75(4). 783–790. 11 indexed citations
15.
Peng, Xingchen, Fanxi Gong, Yunfeng Chen, et al.. (2015). Proteomics identification of PGAM1 as a potential therapeutic target for urothelial bladder cancer. Journal of Proteomics. 132. 85–92. 42 indexed citations
16.
Ding, Jing, Jie Tang, Xin Chen, et al.. (2013). Expression Characteristics of Proteins of the Insulin-like Growth Factor Axis in Non-small Cell Lung Cancer Patients with Preexisting Type 2 Diabetes Mellitus. Asian Pacific Journal of Cancer Prevention. 14(10). 5675–5680. 18 indexed citations
17.
Li, Xiang, Meng Qiu, Ke Cheng, et al.. (2013). Epidermal Growth Factor Receptor (EGFR)-RAS Signaling Pathway in Penile Squamous Cell Carcinoma. PLoS ONE. 8(4). e62175–e62175. 37 indexed citations
18.
Tan, Benxu, Ye Chen, Li V. Yang, et al.. (2011). Interaction of green tea polyphenol epigallocatechin-3-gallate with sunitinib: potential risk of diminished sunitinib bioavailability. Journal of Molecular Medicine. 89(6). 595–602. 66 indexed citations
19.
Peng, Xingchen, Meng Qiu, Benxu Tan, et al.. (2011). Different combination schedules of gemcitabine with endostar affect antitumor efficacy. Cancer Chemotherapy and Pharmacology. 69(1). 239–246. 11 indexed citations
20.
Peng, Xingchen, Fengming Gong, Wei Meng, et al.. (2010). Proteomic analysis of cell lines to identify the irinotecan resistance proteins. Journal of Biosciences. 35(4). 557–564. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alessandra Cocomazzi Breakdown of academic impact, for papers by Graziella Malaponte Breakdown of academic impact, for papers by Young-Soon Na Breakdown of academic impact, for papers by Jietao Lin Breakdown of academic impact, for papers by Binyan Lin Breakdown of academic impact, for papers by Domenico Germano Breakdown of academic impact, for papers by Carolina Ortiz Breakdown of academic impact, for papers by Ruba Al‐Abdulla Breakdown of academic impact, for papers by Eufemia Savino
Rankless by CCL
2026